A randomized, parallel CO2 laser-controlled, multi-center trial of Aminolevulinic-acid in patients with condyloma acuminatum

Trial Profile

A randomized, parallel CO2 laser-controlled, multi-center trial of Aminolevulinic-acid in patients with condyloma acuminatum

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Aug 2015

At a glance

  • Drugs Aminolevulinic acid (Primary)
  • Indications Condylomata acuminata
  • Focus Therapeutic Use
  • Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
  • Most Recent Events

    • 18 Aug 2015 Results published in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical website.
    • 18 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top